IQVIA Holdings Inc. (IQV)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for IQV is $276.56, 3.6% above the last close of $266.90 on Oct 16, 2026; targets range from $185.00 to $344.56. Rating consensus: Buy.
Snapshot
- P/E33.1x
- P/E vs sector+17.6%
- P/E vs own+32.7%
- Target upside+3.6%
- ConsensusBuy
- Market cap$43.93B
- FCF yield+5.9%
- Insiders-$29.89M
- Earnings in11d
- News0.00
Why it moved
IQVIA Holdings Inc. (IQV) fell 1.5% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
0 stories on the day (30-day average 1.2).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $266.90 · +29.7% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendbullish
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50↓ in ~7d
- RSI55
- Support-3.5%
- Resistance+2.4%
- Off 52w high-3.0%
- Off ATH-5.6%
- 52w range$266.90
- Bollingerupper half
- MACD-0.27
- ATR+2.8%
- Volume0.8x
Analyst price targets
12 firms with a target in the last 12 months · last close $266.90 · as of Oct 16, 2026
Strong buy 3 · Buy 16 · Hold 3 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q2 FY2026: Revenue +8.7% year over year, free cash flow 8.2% of revenue, operating margin 11.6%.
| Q2 FY2026 | Jun 30, 2026 | $4.37B | 1.53 | $360M | 32.9% | 11.6% | 5.9% |
| Q1 FY2026 | Mar 31, 2026 | $4.15B | 1.61 | $491M | 32.6% | 12.4% | 6.6% |
| Q4 FY2025 | Dec 31, 2025 | $4.36B | 2.99 | $561M | 6.7% | 16.8% | 11.8% |
| Q3 FY2025 | Sep 30, 2025 | $4.1B | 1.93 | $1.2B | 33.5% | 13.5% | 8.1% |
| Q2 FY2025 | Jun 30, 2025 | $4.02B | 1.54 | $292M | 32.9% | 12.6% | 6.6% |
| Q1 FY2025 | Mar 31, 2025 | $3.83B | 1.40 | $426M | 33.9% | 13.0% | 6.5% |
| Q4 FY2024 | Dec 31, 2024 | $3.96B | 2.42 | $721M | 34.8% | 15.8% | 11.0% |
| Q3 FY2024 | Sep 30, 2024 | $3.9B | 1.55 | $571M | 35.4% | 14.1% | 7.3% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $172.97 | -1.5% | -1.5% | +0.5% | 34.0 | $48.77B | |
| 2 |  | $560.36 | +2.4% | -26.9% | +34.9% | 39.7 | $44.15B | |
| 3 | | $266.90 | -1.5% | -3.0% | +3.6% | 33.1 | $43.93B | |
| 4 |  | $436.95 | -1.6% | -1.6% | +4.4% | 109.0 | $42.9B | |
| 5 |  | $262.54 | -2.0% | -10.6% | -16.6% | 49.0 | $39.64B | |
| 6 |  | $1,622.29 | -1.0% | -1.0% | -7.3% | 36.5 | $32.51B | |
| 7 |  | $235.00 | -1.7% | -4.7% | -0.5% | 24.9 | $25.94B | |
| 8 |  | $317.95 | -2.2% | -6.1% | +5.8% | 26.3 | $25.79B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.